cepharanthine has been researched along with Adenocarcinoma of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, G; Qiao, K; Wang, C; Xu, X | 1 |
| Chen, P; Jia, J; Liu, Y; Wang, Y; Xiu, R; Yi, J; Zhang, G; Zhang, X; Zhao, Z | 1 |
2 other study(ies) available for cepharanthine and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Cepharanthine Regulates Autophagy via Activating the p38 Signaling Pathway in Lung Adenocarcinoma Cells.
Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Autophagy; Benzylisoquinolines; Cell Proliferation; Humans; Lung Neoplasms; Signal Transduction | 2022 |
Cepharanthine, a novel selective ANO1 inhibitor with potential for lung adenocarcinoma therapy.
Topics: Adenocarcinoma of Lung; Animals; Anoctamin-1; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Binding Sites; CHO Cells; Cricetinae; Cricetulus; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Protein Binding | 2021 |